CIK 0001768224
- Accelerated filer
- Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 858-900-2660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- 4 Planned sale Chief Scientific Officer & COO sold 8,565 shares at $35.01 ($299,839)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $18.72 ($93,602)
- 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $25.61 ($128,062)
- 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $31.45 ($157,264)
- 4 Grant or award Chief Financial Officer acquired 1,223 shares (grant or award)
- 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $34.91 ($174,550)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Scientific Officer & COO sold 25,000 shares at $35.01 ($875,250)
- 4 Open-market sale See Remarks sold 6,968 shares at $35.00 ($243,880)
- 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $28.75 ($143,750)
Page 3 of 8 · 149 filings